Estrogen and Selective Estrogen Receptor Modulators: Neuroprotection in the Women's Health Initiative Era

By Murphy Stephanie J.   McCullough Louise D.   Littleton-Kearney Marguerite T.   Hurn Patricia D.  

Endocrine Journal, Vol. 21, Iss. 1, 2003-06 ,pp. : 17-26

Humana Press, Inc

Access to resources Recommend Favorite

Neuroendocrine effects of raloxifene hydrochloride in postmenopausal women

By Florio P.   Quirici B.   Casarosa E.   Lombardi I.   Luisi M.   Genazzani A. D.   Petraglia F.   Genazzani A. R.  

Gynecological Endocrinology, Vol. 15, Iss. 5, 2001-10 ,pp. : 359-366

Informa Healthcare

Access to resources Recommend Favorite

Concentration-dependent effects of a selective estrogen receptor modulator raloxifene on proliferation and apoptosis in human uterine leiomyoma cells cultured in vitro

By Liu Jin   Matsuo Hiroya   Xu Qin   Chen Wei   Wang Jiayin   Maruo Takeshi  

Human Reproduction, Vol. 22, Iss. 5, 2007-05 ,pp. : 1253-1259

Oxford University Press

Access to resources Recommend Favorite

Effects of estrogen replacement therapy on pituitary size, prolactin and thyroid-stimulating hormone concentrations in menopausal women

By Abech Denise   Moratelli Hélio   Leite Sérgio   Oliveira Miriam  

Gynecological Endocrinology, Vol. 21, Iss. 4, 2005-10 ,pp. : 223-226

Informa Healthcare

Access to resources Recommend Favorite

Selective Estrogen Receptor Modulators and Coronary Heart Disease

By Bian Z.   Nilsson S.   Gustafsson J.-.  

Trends in Cardiovascular Medicine, Vol. 11, Iss. 5, 2001-07 ,pp. : 196-202

Elsevier

Access to resources Recommend Favorite